Abstract
Systemic sclerosis is a disease of typically middle aged women, with significant morbidity and mortality predominantly caused by lung involvement. Screening for and diagnosis of interstitial lung disease is critical given the decreased survival associated with progressive fibrotic lung disease. Monitoring of disease is necessary once the diagnosis has been made, and surgical lung biopsy is usually unnecessary. Treatment centers on immunosuppressants without additional steroids with attention to identification and management of co-existing complications, such as pulmonary hypertension and gastro-esophageal reflux, as well as supportive therapy with supplemental oxygen and exercise. Referral for lung transplant evaluation should be considered when there is persistent progression.
Keywords: Fibrosis, interstitial lung disease (ILD), review, scleroderma, severe.
Current Respiratory Medicine Reviews
Title:Systemic Sclerosis Associated Interstitial Lung Disease
Volume: 11 Issue: 2
Author(s): Virginia Steen and Nargues Weir
Affiliation:
Keywords: Fibrosis, interstitial lung disease (ILD), review, scleroderma, severe.
Abstract: Systemic sclerosis is a disease of typically middle aged women, with significant morbidity and mortality predominantly caused by lung involvement. Screening for and diagnosis of interstitial lung disease is critical given the decreased survival associated with progressive fibrotic lung disease. Monitoring of disease is necessary once the diagnosis has been made, and surgical lung biopsy is usually unnecessary. Treatment centers on immunosuppressants without additional steroids with attention to identification and management of co-existing complications, such as pulmonary hypertension and gastro-esophageal reflux, as well as supportive therapy with supplemental oxygen and exercise. Referral for lung transplant evaluation should be considered when there is persistent progression.
Export Options
About this article
Cite this article as:
Steen Virginia and Weir Nargues, Systemic Sclerosis Associated Interstitial Lung Disease, Current Respiratory Medicine Reviews 2015; 11 (2) . https://dx.doi.org/10.2174/1573398X11666150619183832
DOI https://dx.doi.org/10.2174/1573398X11666150619183832 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Collagen Cross-link Breakers:A Beginning of a New Era in the Treatment of Cardiovascular Changes Associated with Aging,Diabetes,and Hypertension
Current Drug Targets - Cardiovascular & Hematological Disorders Bridging the Gap: The Potential Role of Corticosteroid Binding Globulin in Cardiac Steroid Facilitation
Current Drug Targets Synergistic Effects of Social Isolation and Morphine Addiction on Reduced Neurogenesis and BDNF Levels and the Resultant Deficits in Cognition and Emotional State in Male Rats
Current Molecular Pharmacology The Beneficial Role of Vitamin D in Human Immunodeficiency Virus Infection
Current HIV Research Apoptosis in Anthracycline Cardiomyopathy
Current Pediatric Reviews Parathyroid Hypertension: A Rare, but Curable form of Secondary Hypertension
Current Hypertension Reviews Therapeutic Hypothermia as a Neuroprotective Strategy in Neonatal Hypoxic-Ischemic Brain Injury and Traumatic Brain Injury
Current Molecular Medicine Gender Disparity in Pediatric Diseases
Current Molecular Medicine Targeting Mitochondria for Cardiac Protection
Current Drug Targets “Vascular Incontinence” and Normal-Pressure Hydrocephalus: Two Commonsources of Elderly Incontinence with Brain Etiologies
Current Drug Therapy Effects of Lipid-Lowering Drugs on Adiponectin
Current Vascular Pharmacology Smoking and Hypertension: Effects on Clinical, Biochemical and Pathological Variables Due to Isolated or Combined Action on Cardiovascular System
Current Pharmaceutical Design The Emerging Role of Vascular Endothelial Growth Factor (VEGF) in Vascular Homeostasis: Lessons from Recent Trials with Anti-VEGF Drugs
Current Vascular Pharmacology Similarities and Differences Between Renal Sympathetic Denervation and Carotid Baroreceptor Stimulation
Current Vascular Pharmacology Family History and Preclinical Atherosclerosis
Current Hypertension Reviews Pleiotropic Effects of Statins - Clinical Evidence
Current Pharmaceutical Design Possible Involvement of TRP Channels in Cardiac Hypertrophy and Arrhythmia
Current Topics in Medicinal Chemistry Occurrence and Clinical Impact of Microembolic Signals (MES) in Patients with Chronic Cardiac Diseases and Atheroaortic Plaques - A Systematic Review
Current Vascular Pharmacology Editorial (Thematic Issue: The Life Cycle of the Heart Failure Patient)
Current Cardiology Reviews Point of Care Cardiac Ultrasound Applications in the Emergency Department and Intensive Care Unit - A Review
Current Cardiology Reviews